Literature DB >> 2984080

Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin.

C Niederau, L D Ferrell, J H Grendell.   

Abstract

The onset, course, and regression of the biochemical and structural alterations associated with pancreatitis induced by various doses of caerulein were studied in the mouse. In addition, the protective effect of secretin was compared with that of the cholecystokinin-receptor antagonists proglumide and benzotript. Subcutaneous or intraperitoneal injections of caerulein induced increases in serum amylase concentration and pancreatic weight and histologic evidence of acute pancreatitis, all effects being dose-related. Cytoplasmic vacuoles were the earliest histologic alterations. As the pancreatitis progressed these vacuoles increased to an enormous size. Interstitial inflammation and acinar cell necrosis were prominent after 6 h, reached a maximum after 12 h, and mostly disappeared after 4 days. During the course of pancreatitis approximately 40% of the acinar cells showed signs of severe degeneration or necrosis at the most effective doses of caerulein. Electron microscopy showed both intact and degenerating granules inside the vacuoles. Signs of basolateral exocytosis of zymogen granules were not observed. During the regression of pancreatitis, focal atrophy was a remarkable histologic finding. Repetitive initiation of pancreatitis (six courses of caerulein injections over 5 wk) produced marked focal atrophy and early fibrosis. High doses of proglumide or benzotript markedly ameliorated both the biochemical and structural alterations induced by caerulein. Secretin, even at very high doses, had only minor protective effects. This study presents a model of acute necrotizing pancreatitis in which the severity of the induced pancreatitis ranges dose-dependently from mild interstitial inflammation to severe necrosis. The ultrastructural alterations described herein support the hypothesis that the trigger mechanism of acute pancreatitis appears to be a primary intracellular event rather than an interstitial event that secondarily damages the acinar cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984080     DOI: 10.1016/s0016-5085(85)80079-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  112 in total

1.  Protease activation during in vivo pancreatitis is dependent on calcineurin activation.

Authors:  Ahsan U Shah; Amna Sarwar; Abrahim I Orabi; Samir Gautam; Wayne M Grant; Alexander J Park; Adnan U Shah; Jun Liu; Pramod K Mistry; Dhanpat Jain; Sohail Z Husain
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11       Impact factor: 4.052

2.  Protease-activated receptor-2 protects against pancreatitis by stimulating exocrine secretion.

Authors:  Vijay P Singh; Lakshmi Bhagat; Sarah Navina; Rifat Sharif; Rajinder K Dawra; Ashok K Saluja
Journal:  Gut       Date:  2006-11-17       Impact factor: 23.059

3.  The effect of platelet activating factor antagonist (BN 52021) on cerulein-induced acute pancreatitis with reference to oxygen radicals.

Authors:  A Dabrowski; A Gabryelewicz; L Chyczewski
Journal:  Int J Pancreatol       Date:  1991-01

4.  The effect of chronic intraperitoneal infusion of bacterial endotoxin on exocrine pancreas function in rats.

Authors:  M I Vaccaro; M A Dagrosa; M I Mora; O M Tiscornia; D O Sordelli
Journal:  Int J Pancreatol       Date:  1996-02

Review 5.  Pharmacologic therapy for acute pancreatitis.

Authors:  Swetha Kambhampati; Walter Park; Aida Habtezion
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

6.  Alleviation of cell damage in experimental ANP in rats by administration of chondroitin-sulfate reduces.

Authors:  Zhongye He; Renxuan Guo; Chengyao Xie; Nan Liu; Yang Li; Wen Song
Journal:  Front Med China       Date:  2007-02

7.  Effects of tetraprenylacetone on pancreatic exocrine secretion and acute pancreatitis in two experimental models in rats.

Authors:  I Tachibana; N Watanabe; H Shirohara; T Akiyama; S Nanano; M Otsuki
Journal:  Int J Pancreatol       Date:  1995-04

8.  The effect of platelet activating factor antagonist (BN 52021) on acute experimental pancreatitis with reference to multiorgan oxidative stress.

Authors:  A Dabrowski; A Gabryelewicz; L Chyczewski
Journal:  Int J Pancreatol       Date:  1995-04

9.  Quantitative organellar proteomics analysis of rough endoplasmic reticulum from normal and acute pancreatitis rat pancreas.

Authors:  Xuequn Chen; Maria Dolors Sans; John R Strahler; Alla Karnovsky; Stephen A Ernst; George Michailidis; Philip C Andrews; John A Williams
Journal:  J Proteome Res       Date:  2010-02-05       Impact factor: 4.466

10.  Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin.

Authors:  Daniel S John; Julia Aschenbach; Burkhard Krüger; Matthias Sendler; F Ulrich Weiss; Julia Mayerle; Markus M Lerch; Ali A Aghdassi
Journal:  J Biol Chem       Date:  2018-11-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.